Targeted inhibition of <scp>IL</scp> ‐4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy

Amrita Goyal, Seth Lofgreen, Evan Mariash, Andrea Bershow, Kevin J. Gaddis